Polska Grupa FarmaceutycznaS.A.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2013-08-01
Share capital
290 000 000,00 PLN
Activity description

Polska Grupa Farmaceutyczna S.A. is a leading pharmaceutical distributor in Poland. It delivers medicines and medical products to pharmacies, patients, and local communities, working with more than 450 manufacturers. The company operates 13 regional warehouses and delivers 320 million products to pharmacies each year.

Registered address
Zbąszyńska 3, 91-342 Łódź, Poland
Website
pgf.com.plWebsite active
Phone
Social media
Electronic delivery address
AE:PL-31091-21482-FRBAF-11

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.78bnMedianUSD 873.84kAverageUSD 20.03m
Net profit
This companyUSD -2.25mMedianUSD 28.21kAverageUSD 815.54k
Operating costs
This companyUSD 1.77bnMedianUSD 801.08kAverageUSD 18.78m
Assets
This companyUSD 583.58mMedianUSD 539.29kAverageUSD 10.66m

Bank accounts

Registered as a VAT taxpayer on 2010-12-23. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication dateEvent
Feb 15, 2021Lost documents
Oct 13, 2017Merger registered
Aug 22, 2013Transformation registered

Public aid

35 public aid cases recorded, with a total value of $246,936.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$1,690
De minimis aid (in accordance with Commission Regulation 2023/2831)
$7,910
De minimis aid (in accordance with Commission Regulation 2023/2831)
$4,400

Tenders

3 tenders recorded as contractor: 1 national ($59,916) and 2 EU ($743,357).

SubjectAmount
Zakup i dostawa produktów farmaceutycznych IV
$638.5K
Zakup i dostawa produktów farmaceutycznych IV
$104.8K
Dostawy radiofarmaceutyków i odczynników do ZMN
$59,916

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Bartosz Kędzierski — Attorney-in-fact (joint)
Ewa Olczyk Papis — Attorney-in-fact (joint)
Łukasz Grzelak — Attorney-in-fact (joint)
Piotr Robert Jucha — President of the Management Board
Marek Lipka — Management Board Member

Manner of representation

For the validity of declarations of will made on behalf of the company, joint action of two members of the management board or of one member of the management board together with a commercial proxy is required. The commercial proxy makes declarations of will on behalf of the company jointly with one member of the management board.

Supervisory board

Mariola Belina Prażmowska — Supervisory Board Member
Jacek Dauenhauer — Supervisory Board Member
Ignacy Przystalski — Supervisory Board Member
Jacek Szwajcowski — Supervisory Board Member
Zbigniew Molenda — Supervisory Board Member

Ownership

Beneficial owners

Person
Zbigniew Molenda (63)
Jacek Szwajcowski (62)

Subsidiaries

NameStake
60.9539%
100%
Pure Medicsp. z o.o.
100%

Competitors

Name
Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawexsp. z o.o.
HurtapS.A.
Sanofisp. z o.o.
Przedsiębiorstwo Zaopatrzenia Aptek Multi PharmeS.A.
LubfarmS.A.
PolypharmS.A.
Cardinal PharmaS.A.
Farmbudsp. z o.o.
CanpolandS.A.
Apteczka Pacjentasp. z o.o.

Change history

DateEvent
2024-09-04Share capital change
2021-05-28Share capital change
2015-02-27PKD change
2013-08-01Entered in the register

FAQ

Last updated: 2026-07-28